2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
- PMID: 26318161
- DOI: 10.1183/13993003.01032-2015
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Erratum in
-
"2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)." Nazzareno Galiè, Marc Humbert, Jean-Luc Vachiery, Simon Gibbs, Irene Lang, Adam Torbicki, Gérald Simonneau, Andrew Peacock, Anton Vonk Noordegraaf, Maurice Beghetti, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, Georg Hansmann, Walter Klepetko, Patrizio Lancellotti, Marco Matucci, Theresa McDonagh, Luc A. Pierard, Pedro T. Trindade, Maurizio Zompatori and Marius Hoeper. Eur Respir J 2015; 46: 903-975.Eur Respir J. 2015 Dec;46(6):1855-6. doi: 10.1183/13993003.51032-2015. Eur Respir J. 2015. PMID: 26621899 No abstract available.
Abstract
Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome, as well as the risk-benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help health professionals to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate.
Published on behalf of the European Society of Cardiology and European Respiratory Society. All rights reserved. © 2015 European Society of Cardiology & European Respiratory Society.
Similar articles
-
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29. Eur Heart J. 2016. PMID: 26320113 No abstract available.
-
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).Eur Heart J. 2009 Oct;30(20):2493-537. doi: 10.1093/eurheartj/ehp297. Epub 2009 Aug 27. Eur Heart J. 2009. PMID: 19713419 No abstract available.
-
[ESC guidelines 2015 pulmonary hypertension: diagnosis and treatment].Dtsch Med Wochenschr. 2016 Nov;141(24):1764-1769. doi: 10.1055/s-0042-117784. Epub 2016 Nov 30. Dtsch Med Wochenschr. 2016. PMID: 27903027 German.
-
Review of the International Society for Heart and Lung Transplantation Practice guidelines for management of heart failure in children.Cardiol Young. 2015 Aug;25 Suppl 2:154-9. doi: 10.1017/S1047951115000955. Cardiol Young. 2015. PMID: 26377722 Review.
-
Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.Heart. 2016 May;102 Suppl 2:ii86-100. doi: 10.1136/heartjnl-2015-309132. Heart. 2016. PMID: 27053701
Cited by
-
Comorbidities reduce survival and quality of life in COPD with severe lung hyperinflation.ERJ Open Res. 2024 Nov 18;10(6):00268-2024. doi: 10.1183/23120541.00268-2024. eCollection 2024 Nov. ERJ Open Res. 2024. PMID: 39559450 Free PMC article.
-
Novel Noninvasive Index Combining Echocardiography and Computed Tomography for Screening for Pulmonary Hypertension in Patients With Systemic Sclerosis.CJC Open. 2024 May 17;6(9):1050-1057. doi: 10.1016/j.cjco.2024.05.005. eCollection 2024 Sep. CJC Open. 2024. PMID: 39525826 Free PMC article.
-
Pulmonary hypertension in adults with congenital heart defects (ACHDs)-in light of the 2022 ESC PAH guidelines-part I: definition, epidemiology, classification, diagnostics, genetics, risk stratification and follow-up, gender aspects.Cardiovasc Diagn Ther. 2024 Oct 31;14(5):935-948. doi: 10.21037/cdt-24-148. Epub 2024 Oct 22. Cardiovasc Diagn Ther. 2024. PMID: 39513141 Free PMC article. Review.
-
Effects of acetazolamide on sleep disordered breathing in pulmonary vascular disease: a randomised controlled trial.ERJ Open Res. 2024 Oct 28;10(5):00040-2024. doi: 10.1183/23120541.00040-2024. eCollection 2024 Sep. ERJ Open Res. 2024. PMID: 39469274 Free PMC article.
-
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension.Front Cardiovasc Med. 2024 Oct 14;11:1430903. doi: 10.3389/fcvm.2024.1430903. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39469124 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical